Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Die wichtigsten Gesundheitsnachrichten dieser Woche: UnitedHealth, Medtronic und Eli Lilly im Fokus. Die S&P 500-Healthcare-Index-Sektoren (XLV) stiegen um 2,46% während der Woche an. Top-Gewinner waren Humana (+14,62%), Medtronic (+10,65%) und The Cooper Companies (+10,01%).

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Die Weltbevölkerung altert schnell, was sich auf die Ansätze der Gesundheitssysteme, Unternehmen und Investoren zur langfristigen Wachstumschancen auswirkt. Laut den neuesten Daten der Weltgesundheitsorganisation übertraf die Anzahl der Menschen im Alter von 60 Jahren und älter die Zahl der Kinder unter fünf Jahren weltweit im Jahr 2020, was ein historischer demografischer Wendepunkt darstellt. Die Weltbevölkerung im Alter von 60 Jahren und älter wird sich zwischen 2020 und 2050 verdoppeln auf 2,1 Milliarden. Die Anzahl der Personen im Alter von 80 Jahren oder älter wird sich zwischen 2020 und 2050 verdreifachen auf 426 Millionen.

Diese demografische Übergang öffnet ein Multitrillionen-Dollar-Gesundheitswachstumspotential. Global Market Insights schätzt den globalen geriatrischen Pflegedienstmarkt auf über 2,1 Billionen Dollar bis 2034, mit einem jährlichen Wachstumsrate von 5,1 %, getrieben durch steigende Lebenserwartung, zunehmende chronische Krankheiten und wachsende Nachfrage nach heimischen und digital vernetzten Pflegelösungen.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Die Danaher Corporation (NYSE:DHR) war eines der Unternehmen, über das Jim Cramer seine Meinung teilte. Er sagte, dass Dotcom-Analogien in diesem Markt nicht zutreffen. Cramer nannte es eine "eine Zeit excellent Company", da er sagte: ...

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

CNBC-Experte Jim Cramer sagte, dass die heutige Marktsituation viel brutaler sei als die Dotcom-Bubble von 1999. Er kritisiert, dass Unternehmen, die ihre Gewinnprognosen nicht erfüllen, noch härter bestraft werden als damals. Der S&P 500 und der Nasdaq Composite schlossen am Montag bei Rekordhöhen, aber Cramer warnt vor einer möglichen Korrektur.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Von den 22 S&P 500 Gesundheitsunternehmen, die in dieser Woche Ergebnisse veröffentlicht haben, haben 19 die Erwartungen übertroffen und 15 einen jährlichen EPS-Wachstum von über 86% aufgezeigt. Alle 22 Unternehmen zeigten ein jährliches Umsatzwachstum, wobei nur zwei die Top-Linie bei den Schätzungen verpassten.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the patient monitoring stocks, including Insulet (NASDAQ:PODD) and its peers.

Patient monitoring companies within the healthcare equipment industry offer devices and technologies that track chronic conditions and support real-time health management, such as continuous glucose monitors (CGMs) and sleep apnea machines. These businesses benefit from recurring revenue from consumables and software subscriptions tied to device sales (razor, razor blade model). The rising prevalence of chronic diseases like diabetes and respiratory disorders due to an aging population as well as growing adoption of digitization are good for the industry. However, these companies face challenges from high R&D costs and reliance on regulatory approvals. Looking ahead, the sector is positioned for growth due to tailwinds like the rising burden of chronic diseases from an aging population, the shift toward value-based care, and increased adoption of digital health solutions. Innovations in AI and machine learning are expected to enhance device accuracy and functionality, improving patient outcomes and driving demand. However, there are headwinds such as pricing pressures as healthcare costs are a key focus, especially in the US. An evolving regulatory landscape and competition from more tech-forward new entrants could present additional challenges.

The 4 patient monitoring stocks we track reported a strong Q4. As a group, revenues beat analysts’ consensus estimates by 1.9% while next quarter’s revenue guidance was 1.9% below.

Amidst this news, share prices of the companies have had a rough stretch. On average, they are down 16% since the latest earnings results.

Insulet (NASDAQ:PODD)

Revolutionizing diabetes care with its tubeless "Pod" technology, Insulet (NASDAQ:PODD) develops and manufactures innovative insulin delivery systems for people with diabetes, primarily through its Omnipod product line.

Insulet reported revenues of $783.8 million, up 31.2% year on year. This print exceeded analysts’ expectations by 2%. Overall, it was a strong quarter for the company with an impressive beat of analysts’ revenue and EPS estimates.

“We ended the year with another excellent quarter, demonstrating the power of our business model, the strength of our technology, and the disciplined execution of our team,” said Ashley McEvoy, President and CEO.Insulet Total Revenue

Insulet scored the fastest revenue growth of the whole group. Investor expectations, however, were likely higher than Wall Street’s published projections, leaving some wishing for even better results (analysts’ consensus estimates are those published by big banks and advisory firms, not the investors who make buy and sell decisions). The stock is down 16% since reporting and currently trades at $206.93.

Story Continues

Read why we think that Insulet is one of the best patient monitoring stocks, our full report is free.

Best Q4: iRhythm (NASDAQ:IRTC)

Pioneering the shift from bulky, short-term heart monitors to sleek, wire-free patches, iRhythm Technologies (NASDAQ:IRTC) provides wearable cardiac monitoring devices and AI-powered analysis services that help physicians detect and diagnose heart rhythm disorders.

iRhythm reported revenues of $208.9 million, up 27.1% year on year, outperforming analysts’ expectations by 3.4%. The business had a very strong quarter with a beat of analysts’ EPS and revenue estimates.iRhythm Total Revenue

iRhythm delivered the biggest analyst estimates beat and highest full-year guidance raise among its peers. Although it had a fine quarter compared to its peers, the market seems unhappy with the results as the stock is down 28.1% since reporting. It currently trades at $114.25.

Is now the time to buy iRhythm? Access our full analysis of the earnings results here, it’s free.

Slowest Q4: DexCom (NASDAQ:DXCM)

Founded in 1999 and receiving its first FDA approval in 2006, DexCom (NASDAQ:DXCM) develops and sells continuous glucose monitoring systems that allow people with diabetes to track their blood sugar levels without repeated finger pricks.

DexCom reported revenues of $1.26 billion, up 13.1% year on year, exceeding analysts’ expectations by 0.8%. Still, it was a mixed quarter as it posted full-year revenue guidance meeting analysts’ expectations.

DexCom delivered the weakest performance against analyst estimates and weakest full-year guidance update in the group. As expected, the stock is down 4.9% since the results and currently trades at $61.86.

Read our full analysis of DexCom’s results here.

ResMed (NYSE:RMD)

Founded in 1989 to address the then-underdiagnosed condition of sleep apnea, ResMed (NYSE:RMD) develops cloud-connected medical devices and software solutions that treat sleep apnea, COPD, and other respiratory disorders for home and clinical use.

ResMed reported revenues of $1.42 billion, up 11% year on year. This number surpassed analysts’ expectations by 1.6%. Overall, it was a strong quarter as it also logged a decent beat of analysts’ revenue estimates and a beat of analysts’ EPS estimates.

ResMed had the slowest revenue growth among its peers. The stock is down 15% since reporting and currently trades at $219.04.

Read our full, actionable report on ResMed here, it’s free.

Market Update

Late in 2025 into early 2026, there was hand wringing around artificial intelligence. For software companies, the fear was that AI would erode pricing power and compress margins as new tools made it easier to replicate what once required expensive enterprise platforms. Crypto investors had their own version of the same anxiety: if AI agents could trade, allocate capital, and manage wallets autonomously, what exactly was the long-term value of today’s crypto infrastructure?

These concerns triggered a noticeable rotation away from these sectors and into safer havens. But markets rarely dwell on one narrative for long. Spring 2026 came, and the focus shifted abruptly from technological disruption to geopolitical risk. The US’ conflict with Iran became the dominant driver of market psychology, and when geopolitics takes center stage, the script changes quickly. Investors stop debating growth rates and start worrying about oil supply, inflation, and global stability.

Want to invest in winners with rock-solid fundamentals? Check out our 9 Best Market-Beating Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate.

StockStory’s analyst team — all seasoned professional investors — uses quantitative analysis and automation to deliver market-beating insights faster and with higher quality.

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at patient monitoring stocks, starting with ResMed (NYSE:RMD).

Patient monitoring companies within the healthcare equipment industry offer devices and technologies that track chronic conditions and support real-time health management, such as continuous glucose monitors (CGMs) and sleep apnea machines. These businesses benefit from recurring revenue from consumables and software subscriptions tied to device sales (razor, razor blade model). The rising prevalence of chronic diseases like diabetes and respiratory disorders due to an aging population as well as growing adoption of digitization are good for the industry. However, these companies face challenges from high R&D costs and reliance on regulatory approvals. Looking ahead, the sector is positioned for growth due to tailwinds like the rising burden of chronic diseases from an aging population, the shift toward value-based care, and increased adoption of digital health solutions. Innovations in AI and machine learning are expected to enhance device accuracy and functionality, improving patient outcomes and driving demand. However, there are headwinds such as pricing pressures as healthcare costs are a key focus, especially in the US. An evolving regulatory landscape and competition from more tech-forward new entrants could present additional challenges.

The 4 patient monitoring stocks we track reported a strong Q4. As a group, revenues beat analysts’ consensus estimates by 1.9% while next quarter’s revenue guidance was 1.9% below.

Amidst this news, share prices of the companies have had a rough stretch. On average, they are down 11.4% since the latest earnings results.

ResMed (NYSE:RMD)

Founded in 1989 to address the then-underdiagnosed condition of sleep apnea, ResMed (NYSE:RMD) develops cloud-connected medical devices and software solutions that treat sleep apnea, COPD, and other respiratory disorders for home and clinical use.

ResMed reported revenues of $1.42 billion, up 11% year on year. This print exceeded analysts’ expectations by 1.6%. Overall, it was a strong quarter for the company with a decent beat of analysts’ revenue estimates and a beat of analysts’ EPS estimates.

“Our second quarter results demonstrate the strength and resilience of our global business as we continue advancing our mission to help people sleep better, breathe better, and live longer and healthier lives in the comfort of their own home,” said Resmed’s Chairman and CEO, Mick Farrell.

Story Continues

ResMed Total Revenue

ResMed delivered the slowest revenue growth of the whole group. Unsurprisingly, the stock is down 12.1% since reporting and currently trades at $226.50.

We think ResMed is a good business, but is it a buy today? Read our full report here, it’s free.

Best Q4: iRhythm (NASDAQ:IRTC)

Pioneering the shift from bulky, short-term heart monitors to sleek, wire-free patches, iRhythm Technologies (NASDAQ:IRTC) provides wearable cardiac monitoring devices and AI-powered analysis services that help physicians detect and diagnose heart rhythm disorders.

iRhythm reported revenues of $208.9 million, up 27.1% year on year, outperforming analysts’ expectations by 3.4%. The business had a very strong quarter with a beat of analysts’ EPS estimates and an impressive beat of analysts’ revenue estimates.iRhythm Total Revenue

iRhythm achieved the biggest analyst estimates beat and highest full-year guidance raise among its peers. Although it had a fine quarter compared its peers, the market seems unhappy with the results as the stock is down 23.3% since reporting. It currently trades at $121.81.

Is now the time to buy iRhythm? Access our full analysis of the earnings results here, it’s free.

DexCom (NASDAQ:DXCM)

Founded in 1999 and receiving its first FDA approval in 2006, DexCom (NASDAQ:DXCM) develops and sells continuous glucose monitoring systems that allow people with diabetes to track their blood sugar levels without repeated finger pricks.

DexCom reported revenues of $1.26 billion, up 13.1% year on year, exceeding analysts’ expectations by 0.8%. Still, it was a mixed quarter as it posted full-year revenue guidance meeting analysts’ expectations.

DexCom delivered the weakest performance against analyst estimates and weakest full-year guidance update in the group. Interestingly, the stock is up 3% since the results and currently trades at $67.04.

Read our full analysis of DexCom’s results here.

Insulet (NASDAQ:PODD)

Revolutionizing diabetes care with its tubeless "Pod" technology, Insulet (NASDAQ:PODD) develops and manufactures innovative insulin delivery systems for people with diabetes, primarily through its Omnipod product line.

Insulet reported revenues of $783.8 million, up 31.2% year on year. This print topped analysts’ expectations by 2%. Overall, it was a strong quarter as it also produced a solid beat of analysts’ revenue estimates and a beat of analysts’ EPS estimates.

Insulet pulled off the fastest revenue growth among its peers. The stock is down 13.1% since reporting and currently trades at $214.07.

Read our full, actionable report on Insulet here, it’s free.

Market Update

Late in 2025 into early 2026, there was hand wringing around artificial intelligence. For software companies, the fear was that AI would erode pricing power and compress margins as new tools made it easier to replicate what once required expensive enterprise platforms. Crypto investors had their own version of the same anxiety: if AI agents could trade, allocate capital, and manage wallets autonomously, what exactly was the long-term value of today’s crypto infrastructure?

These concerns triggered a noticeable rotation away from these sectors and into safer havens. But markets rarely dwell on one narrative for long. Spring 2026 came, and the focus shifted abruptly from technological disruption to geopolitical risk. The US’ conflict with Iran became the dominant driver of market psychology, and when geopolitics takes center stage, the script changes quickly. Investors stop debating growth rates and start worrying about oil supply, inflation, and global stability.

Want to invest in winners with rock-solid fundamentals? Check out our Top 5 Quality Compounder Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate.

StockStory’s analyst team — all seasoned professional investors — uses quantitative analysis and automation to deliver market-beating insights faster and with higher quality.

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Custom Market Insights

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Sleep Tech Devices Market size & share revenue was valued at approximately USD 29.30 Billion in 2025 and is expected to reach USD 34.70 Billion in 2026 and is expected to reach around USD 134.60 Billion by 2035, at a CAGR of 18.46% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are ResMed, Koninklijke Philips N.V., Fitbit (Google), Garmin Ltd., Apple Inc., Oura Health Oy, Eight Sleep, Withings, Huawei Technologies Co. Ltd., Xiaomi Corporation, Sleep Number and others.

Austin, TX, USA, March 26, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “ Size, Trends and Insights By Product (Wearables, Sleep Trackers, Smart Beds and Mattresses, Monitoring Devices, Others), By Distribution Channel (Sleep Centers, Pharmacies and Retail Stores, Hospitals, E-Commerce), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2026 – 2035” in its research database.

According to the latest research study, the global Sleep Tech Devices Market was valued at approximately USD 29.30 billion in 2025, is expected to reach USD 34.70 billion in 2026, and is projected to reach around USD 134.60 billion by 2035, with a compound annual growth rate (CAGR) of about 18.46% during the forecast period from 2026 to 2035.

Click Here to Access a Free Sample Report of the Global Sleep Tech Devices Market @ https://www.healthcareforesights.com/request-sample?reportId=1006Sleep Tech Devices Market Size 2025 to 2035 (USD Billion)

Sleep Tech Devices Market Revenue and Trends

The global sleep tech devices market is intended to improve the quality of sleep and deal with sleep disorders with the help of innovative products in the form of wearables, monitoring devices, smart beds, and apps. The worldwide sleep technology equipment market is growing at an exponential pace due to the escalated rates of sleeping disorders such as insomnia and sleep apnea, aging, stress induced by current lifestyles, and AI-based gadgets, sensors, and telehealth systems in healthcare systems across the globe.

Request a Customized Copy of the Sleep Tech Devices Market Report @https://www.healthcareforesights.com/request-customization?reportId=1006

What are the Factors That Have a Significant Contribution to the Growth of the sleep tech devices market?

The time-consuming factors such as urbanization, sedentary living, screens' blue light, and work-related stress have contributed to the growth in sleep-related problems, including insomnia, obstructive sleep apnea, and poor sleep hygiene, which has increased the demand for sleep tech products. Statistics provided by the American Academy of Sleep Medicine indicate that approximately 30 percent of adults experience brief insomnia, and an increased number of people have this problem in older age. With the aging of the world population aged 65 years and above, more people will be on the hunt for sleep monitors and smart mattresses and therapeutic sleep devices to help them get more sleep and improve their health.

Story Continues

The technological advancement has offered AI wearables, contactless trackers, personalized sleep training applications, and non-invasive therapies to enhance precision, user adherence, and performance. Other forces are the increased understanding of the importance of sleep in overall health, the increased availability of sleep clinics and digital health, and government-supported sleep health screening and education in both developed and emerging markets.

(A free sample of the Sleep Tech Devices report is available upon request; please contact us for more information.)

Our Free Sample Report Consists of the following:

The updated report for 2026 includes an introduction, an overview, and an in-depth industry analysis. Provide detailed chapter-by-chapter guidance on the Request. Updated Regional Analysis with a Graphical Representation of Size, Share, and Trends for the Year 2026 Includes Tables and figures that have been updated. The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis Healthcare Foresights (HEALTHCARE FORESIGHTS) research methodology

Request a Customized Copy of the Sleep Tech Devices Market Report @https://www.healthcareforesights.com/reports/sleep-tech-devices-market

Segment Insight

By Component

According to products, wearables will take the most significant portion of the market of sleep tech devices by 2025 due to the demand for smartwatches, rings, and sleep-tracking bands that measure heart rate, sleep stages, and breathing parameters. Such devices are essential to identify sleep disorders early, monitor them, and treat them, and innovations in the AI-based analytics and integrations with health applications play a significant role in this case (users are delighted by wearables as they can give them detailed information on how to improve their sleep habits).

By Distribution Channel

Online retail channels have the largest market share and serve as the main point of entry for the consumer who wants convenient purchases or comparisons and direct sales to the consumer. Such sites provide professional reviews, online appointments, and convenient shipping of devices that handle sleep disorders, thus they are the best option among technologically advanced users with the need to treat long term sleeping disorders.

Request a Customized Copy of the Sleep Tech Devices Market Report @ https://www.healthcareforesights.com/reports/sleep-tech-devices-market

Key questions answered in this report:

What is the size of the Sleep Tech Devices market, and what is its expected growth rate? What are the primary driving factors that push the Sleep Tech Devices market forward? What are the Sleep Tech Devices Industry's top companies? What are the different categories that the Sleep Tech Devices Market caters to? What will be the fastest-growing segment or region? In the value chain, what role do essential players play? What is the procedure for getting a free copy of the Sleep Tech Devices market sample report and company profiles?

Buy Now Sleep Tech Devices Market Report @ https://www.healthcareforesights.com/checkout/1006

Key Offerings:

Market Share, Size & Forecast by Revenue | 2026−2035 Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Leading Trends Market Segmentation – A detailed analysis by Types of Services, by End-User Services, and by regions Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Buy this Premium Sleep Tech Devices Research Report | Fast Delivery Available - [220+ Pages] @ https://www.healthcareforesights.com/reports/sleep-tech-devices-market

Regional Insights

The sleep tech devices market in North America is the most dominant in the world since the area possesses a well-developed healthcare system, its consumers are more aware of sleep health, and they have access to the latest devices such as AI-powered trackers. The area has a sound reimbursement policy, wide access to sleep experts, and early adoption of digital health technologies. The presence of major players, as well as the ongoing R&D and innovation, strengthens the dominance of North America.

In the meantime, the Asia Pacific region is recording the greatest rate of expansion in the sleep tech equipment market due to a high population base, increased prevalence of sleep illnesses as a result of urbanization and industrialization, and the development of better health systems. There is an increasing adoption of low-cost wearables and monitors in countries such as China, India, and Japan due to the rising affordability, social awareness campaigns, and the implementation of sleep health initiatives by governments. The fast pace of digital uptake and economic development also enhances market growth in Asia Pacific.

Request a Customized Copy of the Sleep Tech Devices Market Report @ https://www.healthcareforesights.com/reports/sleep-tech-devices-market

We customize your report to align with your specific research requirements. Inquire with our sales team about customizing your report.)

Still Looking for More Information? Do you want data for inclusion in magazines, case studies, research papers, or media?

Email Directly Here with Detailed Information: support@custommarketinsights.com

Browse the full “Sleep Tech Devices Market Size, Trends and Insights By Product (Wearables, Sleep Trackers, Smart Beds and Mattresses, Monitoring Devices, Others), By Distribution Channel (Sleep Centers, Pharmacies and Retail Stores, Hospitals, E-Commerce), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2026 – 2035” Report at https://www.healthcareforesights.com/reports/sleep-tech-devices-market

Report Scope

Feature of the Report Details Market Size in 2026 USD 34.70 billion Projected Market Size in 2035 USD 134.60 billion Market Size in 2025 USD 29.30 billion CAGR Growth Rate 18.46% CAGR Base Year 2025 Forecast Period 2026-2035 Key Segment By Product, Distribution Channel and Region Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America Buying Options Request tailored purchasing options to fulfil your requirements for research.

Recent Developments

In October 2024: Oura introduced the Oura Ring 4, which has Smart Sensing technology and 18 signal pathways, which enhance the precision of sleep staging, blood oxygen, and general health tracking and personalized insights due to the integration of the AI. (Source: https://ouraring.com/)North America Sleep Tech Devices Market Size 2025 to 2035 (USD Billion)

List of the prominent players in the Sleep Tech Devices Market:

ResMed Koninklijke Philips N.V. Fitbit (Google) Garmin Ltd. Apple Inc. Oura Health Oy Eight Sleep Withings Huawei Technologies Co. Ltd. Xiaomi Corporation Sleep Number Others

Click Here to Access a Free Sample Report of the Global Sleep Tech Devices Market @  https://www.healthcareforesights.com/reports/sleep-tech-devices-market

Spectacular Deals

Comprehensive coverage Maximum number of market tables and figures The subscription-based option is offered. Best price guarantee Free 35% or 60 hours of customization. Free post-sale service assistance. 25% discount on your next purchase. Service guarantees are available. A personalized market brief by the author.

Browse More Related Reports:

Transgenic Animals Market

Density Gradient Media Market

Decentralized Clinical Trials Market

RNA Targeting Small Molecule Drug Discovery Market

US Over-the-Counter (OTC) Drugs Market

US Ophthalmic Drugs Market

Dental Collagen Membranes Market

Synthetic Bone Graft Substitutes Market

Japan Epigenetics Market

US Cell-Based Assays Market

The Sleep Tech Devices Market is segmented as follows:

By Product

Wearables Sleep Trackers Smart Beds and Mattresses Monitoring Devices Others

By Distribution Channel

Sleep Centers Pharmacies and Retail Stores Hospitals E-Commerce

Click Here to Get a Free Sample Report of the Global Sleep Tech Devices Market @ https://www.healthcareforesights.com/reports/sleep-tech-devices-market

Regional Coverage:

North America

U.S. Canada Mexico Rest of North America

Europe

Germany France U.K. Russia Italy Spain Netherlands Rest of Europe

Asia Pacific

China Japan India New Zealand Australia South Korea Taiwan Rest of Asia Pacific

The Middle East & Africa

Saudi Arabia UAE Egypt Kuwait South Africa Rest of the Middle East & Africa

Latin America

Brazil Argentina Rest of Latin America

This Sleep Tech Devices Market Research/Analysis Report Contains Answers to the following Questions.

What Developments Are Going On in That Technology? Which Trends Are Causing These Developments? Who Are the Global Key Players in This Sleep Tech Devices Market? What are the company profiles, product information, and contact details for these key players? What Was the Global Market Status of the Sleep Tech Devices Market? What Was the Capacity, Production Value, Cost, and PROFIT of the Sleep Tech Devices Market? What Is the Current Market Status of the Sleep Tech Devices Industry? What's the market's competition in this industry, both company-wise and country-wise? What's Market Analysis of Sleep Tech Devices Market by Considering Applications and Types? What Are Projections of the Global Sleep Tech Devices Industry Considering Capacity, Production, and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply, and Consumption? What about imports and exports? What is a Sleep Tech Devices market chain analysis of upstream raw materials and downstream industries? What is the economic impact on the Sleep Tech Devices industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends? What Are the Market Dynamics of the Sleep Tech Devices Market? What Are Challenges and Opportunities? What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Sleep Tech Devices Industry?

Click Here to Access a Free Sample Report of the Global Sleep Tech Devices Market @  https://www.healthcareforesights.com/reports/sleep-tech-devices-market

Reasons to Purchase Sleep Tech Devices Market Report

The Sleep Tech Devices Market Report provides qualitative and quantitative analysis of the market based on segmentation involving economic and non-economic factors. Sleep Tech Devices The Market report outlines market value (USD) data for each segment and sub-segment. This report indicates the region and segment expected to witness the fastest growth and dominate the market. Sleep Tech Devices Market Analysis by geography highlights the consumption of the product/service in the region and indicates the factors affecting the market within each region. The competitive landscape incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled. Extensive company profiles comprise a company overview, company insights, product benchmarking, and SWOT analysis for the major market players. Recent developments, including growth opportunities and drivers, as well as challenges and restraints in both emerging and developed regions, shape the industry's current and future market outlook. Sleep Tech Devices Market: Includes in-depth market analysis from various perspectives through Porter's five forces analysis and offers an overview of the market through the value chain.

Reasons for the Research Report

The study provides a thorough overview of the global Sleep Tech Devices market. Compare your performance to that of the market as a whole.

Aim to maintain competitiveness while innovations from established leaders drive market growth.

Buy this Premium Sleep Tech Devices Research Report | Fast Delivery Available - [220+ Pages] @ https://www.healthcareforesights.com/reports/sleep-tech-devices-market

What does the report include?

Drivers, restrictions, and opportunities are among the qualitative elements covered in the worldwide Sleep Tech Devices market analysis.

The report covers the competitive environment of current and potential participants in the Sleep Tech Devices market, along with their strategic product development ambitions.

This study conducts a qualitative and quantitative analysis of the Sleep Tech Devices market based on the component, application, and industry vertical. Additionally, the report provides comparable data for the key regions.

The report provides actual market sizes and forecasts for each segment mentioned above.

Who should buy this report?

Participants and stakeholders worldwide Sleep Tech Devices market should find this report useful. The research will be useful to all market participants in the Sleep Tech Devices industry.

Managers in the Sleep Tech Devices sector are interested in publishing up-to-date and projected data about the worldwide Sleep Tech Devices market.

Governmental agencies, regulatory bodies, decision-makers, and organizations want to invest in Sleep Tech devices' market trends.

Analysts, researchers, educators, strategy managers, and government organizations seek market insights to develop plans.

Request a Customized Copy of the Sleep Tech Devices Market Report @ https://www.healthcareforesights.com/reports/sleep-tech-devices-market

About Healthcare Foresights:

Healthcare Foresights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains.

Healthcare Foresights is a one-stop solution for data collection and investment advice. Our company's expert analysis digs out essential factors that help us understand the significance and impact of market dynamics. The professional experts advise clients on aspects such as strategies for future estimation, forecasting, opportunities to grow, and consumer surveys.

Follow Us: LinkedIn | Twitter | Facebook | Instagram

Contact Us:

Frank Gittens

CMI Consulting LLC

701 Tillery Street Unit 12-1333

Austin, Texas 78702

United States

USA: +1 737-734-2707

APAC: +91 20 46022736

WhatsApp No : +1 801 639 9061

Email: support@healthcareforesights.com

Blog: https://www.healthcareforesights.com/

Blog: https://www.cmiconsultingllc.com/

Buy this Premium Sleep Tech Devices Research Report | Fast Delivery Available - [220+ Pages] @ https://www.healthcareforesights.com/reports/sleep-tech-devices-market

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at iRhythm (NASDAQ:IRTC) and its peers.

Patient monitoring companies within the healthcare equipment industry offer devices and technologies that track chronic conditions and support real-time health management, such as continuous glucose monitors (CGMs) and sleep apnea machines. These businesses benefit from recurring revenue from consumables and software subscriptions tied to device sales (razor, razor blade model). The rising prevalence of chronic diseases like diabetes and respiratory disorders due to an aging population as well as growing adoption of digitization are good for the industry. However, these companies face challenges from high R&D costs and reliance on regulatory approvals. Looking ahead, the sector is positioned for growth due to tailwinds like the rising burden of chronic diseases from an aging population, the shift toward value-based care, and increased adoption of digital health solutions. Innovations in AI and machine learning are expected to enhance device accuracy and functionality, improving patient outcomes and driving demand. However, there are headwinds such as pricing pressures as healthcare costs are a key focus, especially in the US. An evolving regulatory landscape and competition from more tech-forward new entrants could present additional challenges.

The 4 patient monitoring stocks we track reported a strong Q4. As a group, revenues beat analysts’ consensus estimates by 1.9% while next quarter’s revenue guidance was 1.8% below.

Amidst this news, share prices of the companies have had a rough stretch. On average, they are down 10.5% since the latest earnings results.

Best Q4: iRhythm (NASDAQ:IRTC)

Pioneering the shift from bulky, short-term heart monitors to sleek, wire-free patches, iRhythm Technologies (NASDAQ:IRTC) provides wearable cardiac monitoring devices and AI-powered analysis services that help physicians detect and diagnose heart rhythm disorders.

iRhythm reported revenues of $208.9 million, up 27.1% year on year. This print exceeded analysts’ expectations by 3.4%. Overall, it was a very strong quarter for the company with a beat of analysts’ EPS estimates and an impressive beat of analysts’ revenue estimates.

“The fourth quarter capped a transformational year for iRhythm,” said Quentin Blackford, President and Chief Executive Officer of iRhythm.iRhythm Total Revenue

iRhythm scored the biggest analyst estimates beat and highest full-year guidance raise of the whole group. Investor expectations, however, were likely higher than Wall Street’s published projections, leaving some wishing for even better results (analysts’ consensus estimates are those published by big banks and advisory firms, not the investors who make buy and sell decisions). The stock is down 25.7% since reporting and currently trades at $118.09.

Story Continues

Is now the time to buy iRhythm? Access our full analysis of the earnings results here, it’s free.

Insulet (NASDAQ:PODD)

Revolutionizing diabetes care with its tubeless "Pod" technology, Insulet (NASDAQ:PODD) develops and manufactures innovative insulin delivery systems for people with diabetes, primarily through its Omnipod product line.

Insulet reported revenues of $783.8 million, up 31.2% year on year, outperforming analysts’ expectations by 2%. The business had a strong quarter with a solid beat of analysts’ revenue estimates and a beat of analysts’ EPS estimates.Insulet Total Revenue

Insulet scored the fastest revenue growth among its peers. Although it had a fine quarter compared its peers, the market seems unhappy with the results as the stock is down 7.8% since reporting. It currently trades at $227.08.

Is now the time to buy Insulet? Access our full analysis of the earnings results here, it’s free.

Slowest Q4: DexCom (NASDAQ:DXCM)

Founded in 1999 and receiving its first FDA approval in 2006, DexCom (NASDAQ:DXCM) develops and sells continuous glucose monitoring systems that allow people with diabetes to track their blood sugar levels without repeated finger pricks.

DexCom reported revenues of $1.26 billion, up 13.1% year on year, exceeding analysts’ expectations by 0.8%. Still, it was a mixed quarter as it posted full-year revenue guidance meeting analysts’ expectations.

DexCom delivered the weakest performance against analyst estimates and weakest full-year guidance update in the group. Interestingly, the stock is up 3.4% since the results and currently trades at $67.30.

Read our full analysis of DexCom’s results here.

ResMed (NYSE:RMD)

Founded in 1989 to address the then-underdiagnosed condition of sleep apnea, ResMed (NYSE:RMD) develops cloud-connected medical devices and software solutions that treat sleep apnea, COPD, and other respiratory disorders for home and clinical use.

ResMed reported revenues of $1.42 billion, up 11% year on year. This result topped analysts’ expectations by 1.6%. Overall, it was a strong quarter as it also recorded a decent beat of analysts’ revenue estimates and a beat of analysts’ EPS estimates.

ResMed had the slowest revenue growth among its peers. The stock is down 11.8% since reporting and currently trades at $227.23.

Read our full, actionable report on ResMed here, it’s free.

Market Update

Late in 2025 into early 2026, there was hand wringing around artificial intelligence. For software companies, the fear was that AI would erode pricing power and compress margins as new tools made it easier to replicate what once required expensive enterprise platforms. Crypto investors had their own version of the same anxiety: if AI agents could trade, allocate capital, and manage wallets autonomously, what exactly was the long-term value of today’s crypto infrastructure?

These concerns triggered a noticeable rotation away from these sectors and into safer havens. But markets rarely dwell on one narrative for long. Spring 2026 came, and the focus shifted abruptly from technological disruption to geopolitical risk. The US’ conflict with Iran became the dominant driver of market psychology, and when geopolitics takes center stage, the script changes quickly. Investors stop debating growth rates and start worrying about oil supply, inflation, and global stability.

Want to invest in winners with rock-solid fundamentals? Check out our 9 Best Market-Beating Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate.

StockStory’s analyst team — all seasoned professional investors — uses quantitative analysis and automation to deliver market-beating insights faster and with higher quality.

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Okay, here’s a 600-word summary of the text, followed by a German translation:

Summary: Anti-Snoring Devices Market – Growth Forecast

The anti-snoring devices market is experiencing significant expansion, projected to rise from $1.81 billion in 2025 to $3.36 billion by 2033. This represents a Compound Annual Growth Rate (CAGR) of 8.04% – a robust indicator of sustained market demand. Several key factors are fueling this growth. Firstly, the increasing prevalence of obesity is a major driver, as obesity is a significant contributor to snoring. Secondly, advancements in technology, particularly in device design and effectiveness, are attracting consumers. The preference for non-invasive treatment options over surgical interventions is also playing a crucial role. Strategic initiatives undertaken by major market players and the increased accessibility of these devices through both online and offline channels are further boosting the market.

The growing awareness of the health risks associated with snoring is a fundamental element of this expansion. Snoring is linked to serious conditions such as obstructive sleep apnea, hypertension, heart disease, and sleep deprivation. Individuals are increasingly recognizing the importance of addressing snoring not just for their partner’s comfort but for their own well-being. This heightened awareness directly translates into a greater demand for solutions.

The market is characterized by a diverse range of products designed to tackle the underlying causes of snoring. These include mouthguards, nasal strips, positional aids (designed to encourage side sleeping), and increasingly sophisticated devices that actively manage airflow and muscle relaxation. E-commerce has dramatically altered the landscape, providing consumers with unparalleled access to a wide selection of products and facilitating informed purchasing decisions through online reviews and recommendations.

Several key players dominate the market, including Philips, ResMed, and SomnoMed, which are at the forefront of developing and distributing advanced anti-snoring solutions. New product releases from companies like ZQuiet and ProSomnus demonstrate the ongoing innovation within the sector. The report provides detailed profiles of these key companies, examining their history, business models, operations, workforce, strategic developments (including mergers and acquisitions and partnerships), and sustainability initiatives.

The "Global Anti-Snoring Devices Market" report itself (produced by ResearchAndMarkets.com) offers a comprehensive analysis, covering regional trends, market share analysis, and strategic assessments using SWOT (Strengths, Weaknesses, Opportunities, Threats) analysis for key companies. The report’s 200-page document breaks down the market by region (Global) and forecasts future growth. The report details various attributes such as product profiles, quality standards, and product pipelines.

Ultimately, the anti-snoring device market represents a dynamic and expanding area, driven by a combination of health concerns, technological advancements, and evolving consumer preferences. The report’s forecast highlights significant potential for continued growth and innovation within this sector.

---

German Translation: Markt für Anti-Schnarchgeräte – Wachstumsprognose

Zusammenfassung:

Der Markt für Anti-Schnarchgeräte erlebt ein deutliches Wachstum und wird voraussichtlich von 1,81 Milliarden US-Dollar im Jahr 2025 auf 3,36 Milliarden US-Dollar im Jahr 2033 steigen. Dies entspricht einem durchschnittlichen jährlichen Wachstum von 8,04 % – ein robustes Indiz für die anhaltende Marktnachfrage. Mehrere Schlüsselfaktoren treiben dieses Wachstum an. Erstens ist die zunehmende Prävalenz von Übergewicht ein wesentlicher Faktor, da Übergewicht eine signifikante Ursache für Schnarchattacken ist. Zweitens sind technologische Fortschritte, insbesondere in der Geräteentwicklung und Wirksamkeit, für Verbraucher attraktiv. Die Präferenz für nicht-invasive Behandlungen gegenüber chirurgischen Eingriffen spielt ebenfalls eine wichtige Rolle. Strategische Initiativen, die von wichtigen Marktteilnehmern ergriffen werden, sowie die erhöhte Zugänglichkeit dieser Geräte über Online- und Offline-Kanäle fördern den Markt weiter.

Das wachsende Bewusstsein für die mit Schnarch verbundenen Gesundheitsrisiken ist ein grundlegender Faktor für diese Expansion. Schnarch ist mit schweren Erkrankungen wie obstruktiver Schlafapnoe, Bluthochdruck, Herzerkrankungen und Schlafstörungen verbunden. Einzelpersonen erkennen zunehmend die Bedeutung der Behandlung von Schnarch nicht nur für den Komfort ihres Partners, sondern auch für ihr eigenes Wohlbefinden. Diese gesteigerte Sensibilisierung führt direkt zu einer größeren Nachfrage nach Lösungen.

Der Markt ist durch eine Vielzahl von Produkten gekennzeichnet, die darauf abzielen, die zugrunde liegenden Ursachen von Schnarch zu bekämpfen. Dazu gehören Mundschützer, Nasenstreifen, Positionshilfen (die das Seiten schlafen fördern) und zunehmend ausgefeilte Geräte, die den Luftstrom und die Muskelentspannung aktiv steuern. Der E-Commerce hat die Landschaft grundlegend verändert und Verbrauchern einen unübertroffenen Zugang zu einer breiten Auswahl an Produkten ermöglicht und informierte Kaufentscheidungen durch Online-Bewertungen und Empfehlungen erleichtert.

Mehrere Schlüsselfiguren dominieren den Markt, darunter Philips, ResMed und SomnoMed, die an der Spitze der Entwicklung und Verteilung fortschrittlicher Anti-Schnarchgeräte stehen. Neue Produktentwicklungen von Unternehmen wie ZQuiet und ProSomnus zeigen die kontinuierliche Innovation im Sektor. Der Bericht bietet detaillierte Profile dieser Schlüsselunternehmen und untersucht ihre Geschichte, Geschäftsmodelle, Abläufe, Belegschaft, strategische Entwicklungen (einschließlich Fusionen und Übernahmen und Partnerschaften) und Nachhaltigkeitsinitiativen.

Der “Global Anti-Snoring Devices Market” Bericht (erstellt von ResearchAndMarkets.com) bietet eine umfassende Analyse, die regionale Trends, Marktanteilsanalysen und strategische Bewertungen mithilfe einer SWOT-Analyse (Stärken, Schwächen, Chancen, Bedrohungen) für wichtige Unternehmen umfasst. Der 200-seitige Bericht gliedert den Markt nach Region (Global) und prognostiziert zukünftiges Wachstum. Der Bericht enthält verschiedene Attribute wie Produktprofile, Qualitätsstandards und Produktpipelines.

Letztendlich stellt der Markt für Anti-Schnarchgeräte einen dynamischen und expandierenden Bereich dar, der durch gesundheitliche Bedenken, technologische Fortschritte und sich ändernde Verbraucherpräferenzen angetrieben wird. Die Prognose des Berichts unterstreicht das erhebliche Potenzial für eine kontinuierliche Wachstums- und Innovationsdynamik in diesem Sektor.